Abstract
Central nervous system involvement in HIV infection leads to neurobehavioural sequelae. Although apathy is a well-recognised symptom in adults living with HIV linked to alterations in brain structure, there is scarce research examining motivation in children living with HIV (CLWH). We used the Children’s Motivation Scale (CMS; normative mean = 50, SD = 10) to assess motivation levels in 76 CLWH aged 6–16 years (63 on antiretroviral therapy [ART]; 13 ART-naïve slow progressors) in South Africa. Overall, CLWH scored low on the CMS (mean = 35.70 [SD = 5.87]). Motivation levels were significantly reduced in children taking ART compared to ART-naïve slow progressors (p = 0.02), but were not correlated with markers of HIV disease (CD4 + cell count or viral load), or neurocognitive function (p > 0.05). CMS scores were correlated with diffusion tensor imaging metrics of white matter microstructure in specific frontostriatal brain regions (p < 0.05). On multiple regression, associations with the anterior limb of the internal capsule, a subcortical white matter region, remained significant after adjusting for potential confounders. These findings suggest that reduced motivation may be an important neurobehavioural symptom in CLWH and may reflect changes in white matter microstructure of frontostriatal brain regions.
Similar content being viewed by others
Introduction
There are 1.5 million children living with HIV (CLWH) globally1. HIV typically progresses quickly in children, and without antiretroviral therapy (ART) approximately half will die by the age of two years2, while many others suffer neurodevelopmental delay3,4. Involvement of the central nervous system (CNS) can lead to neurological, cognitive, psychological, and behavioural sequalae in CLWH3,5,6,7,8,9,10,11. The early initiation of ART has substantially improved child outcomes and shifted the focus to long-term neurobehavioural and academic outcomes, and daily functioning12,13, ensuring that children not only survive but also thrive. While in prior guidelines, ART initiation was informed by clinical status and CD4 levels, current guidelines recommend initiating ART on HIV diagnosis. However, only 54% of CLWH are estimated to be receiving ART with little improvement in recent years14. A minority of CLWH who receive no or minimal ART before the age of 10 years are able to maintain virological suppression while remaining clinically asymptomatic, also known as “ART-naïve slow progressors”15,16. Less is known about the outcomes of this population17,18. Understanding the neurobehavioural repercussions of HIV infection in children across the spectrum of disease is critical to optimise provision of care.
Neuropsychological impairment is estimated to occur in over 50% of CLWH without treatment3,11, and CLWH remain at-risk for deficits despite ART5,19. While various behaviours have been examined, to our knowledge only one study has specifically examined motivation levels in CLWH20. Motivation is an important psychological construct that describes the “impetus that gives purpose or direction to behaviour in humans”21. The lack of motivation has been documented as a negative symptom in many neuropsychiatric disorders22, and the impact of diminished motivation has been described in terms of daily living, relationships and employment as well as affecting disease outcomes and chronic medication adherence23. In the single report on motivation in CLWH, HIV was associated with reduced motivation20. In contrast, in adults living with HIV, lack of motivation is a well-recognised neuropsychiatric symptom9,24,25,26,27. In this literature, low motivation not caused by intellectual deficit, emotional disturbance or reduced consciousness, that leads to diminished goal-orientated emotional, cognitive and motor behaviour, is known as ‘apathy’28,29. Apathy has been shown to be present in the absence of depression in adults living with HIV25,30,31,32,33, and to impact daily function34,35, medication adherence25,36, and caregiver distress37. Conceptually, apathy in adults may not be the same as lack of motivation in children, therefore more research is needed to understand this concept in children. This is particularly important given motivation may substantially impact school outcomes, along with self-care and ART adherence38,39, which is often sub-optimal in children40,41. More research into motivation is needed to inform potential intervention strategies.
Studies examining the aetiology of lack of motivation in children of all ages remain scarce. Neuroimaging is a useful tool to understand neuroanatomical pathways underlying cognition and behaviour. Brain changes on neuroimaging have been described in CLWH compared to children without HIV with varying reports at different ages including frontal cortex and subcortical differences; white matter abnormalities are most frequently reported42,43,44. Diffusion tensor imaging (DTI) is a powerful technique for investigating white matter abnormalities seen in HIV17,45,46. White matter microstructural differences across tracts have been seen in CLWH compared to those without HIV47,48,49,50. Separately, some studies have found that DTI metric differences between children with and without HIV are associated with cognition51,52. Given frontostriatal circuits are known to play a role in motivation as well as cognition and behaviour53,54,55, and HIV is known to have a predilection for frontal and subcortical regions56,57,58, it may therefore be hypothesised that HIV-CNS disease in these regions of the brain may precipitate low motivation24,59. However, few studies have been published examining motivation and HIV-related structural brain deficits in children or adolescents. One study in adults showed an inverse correlation between the volume of the nucleus accumbens and apathy59. Two other adult studies have used DTI; one found an association with apathy and white matter tract change in prefrontal areas33, while another showed an association with white matter changes in frontal and basal ganglia regions60, Finally, one adolescent study showed association with impaired global white matter microstructure61. Involvement of the developing CNS makes CLWH particularly vulnerable to disease processes compared to adults61. Understanding the impact of HIV on neurostructural pathways involved in motivation, and the effect of ART, may help determine intervention priorities to support CLWH.
Separately, apathy has also been linked with neurocognitive impairment in some adult studies24,34,62, including deficits on dual-task performance62, assessments of cognition, psychomotor speed and verbal fluency34, and verbal learning and mental flexibility tasks24. However, others show contrasting results and found no evidence of an association between apathy and neurocognitive impairment25,30.
Given the lack of literature on the symptomatology, time course, neuropsychology, or neuroimaging associations of motivation in CLWH, the aim of this study was to examine the association between motivation and: (1) HIV disease markers (as assessed by CD4 + cell count, HIV viral load and treatment status); (2) cognitive function (as assessed by a validated neuropsychological test battery); and (3) white matter microstructure (using diffusion tensor imaging) in CLWH in South Africa. Our hypothesis-based focus was on frontostriatal regions due to prior research on motivation and the predilection of HIV for these areas.
Methods
Participants
This study was nested within a larger project for which ART-naïve and ART-treated CLWH were recruited from Infectious Diseases clinics in two Community Health Centres, and the paediatric neurology service of a tertiary children’s hospital in South Africa, to examine neurocognitive outcomes17,52. Inclusion and exclusion criteria are detailed in full elsewhere17,52,63. In summary, children aged 6–16 years diagnosed with perinatal HIV infection attending an out-patient clinic were included. Children on ART were eligible if they were stable on antiretrovirals for a minimum of 6 months, while children living with HIV who were asymptomatic slow progressors and ART-naïve were also included. Children who were ART-naive but not slow progressors were not included in this study. Those with a history of the following were excluded: medical comorbidities (unstable medical condition including epilepsy and diabetes mellitus); documented CNS neurological conditions (other than HIV); active tuberculosis; head injury with hospital admission or skull fracture; history of traumatic or neurodevelopmental disorder not attributed to HIV; significant perinatal conditions (prematurity, hypoxic ischaemic encephalopathy, jaundice requiring transfusion); maternal drug or alcohol use during pregnancy; clinically significant attention-deficit/hyperactivity disorder, depression, or anxiety that may have affected a child’s performance, assessed using the Beck Youth Inventory and the Conners Parents Rating Scale63; or MRI contraindications. A total of 76 perinatally HIV-infected children completed the Children’s Motivation Scale questionnaire and a comprehensive neuropsychological test battery and had MRI scans performed as part of the larger study procedures.
Instruments and measures
Demographic and socioeconomic information was collected using a demographic questionnaire specifically designed for the purposes of this study as well as the Family Resources Scale (FRS). This is a 30-item scale developed to measure the sufficiency of various resources in homes with young children, including access to healthcare, income, and education. The scale is completed by a parent/caregiver and has been shown to have good test–retest and internal reliability and concurrent validity64.
Children’s Motivation Scale (CMS)
Motivation was measured using the Children’s Motivation Scale (CMS). The CMS is a validated 16-item parent-completed questionnaire developed to assess a child’s motivation65. The scale was developed from the Adult Evaluation Scale (AES) which has been used with success in adults living with HIV29. Parents rate their child’s level of motivation for various activities using a five-point Likert-type scale by responding to questions, for example asking if the child starts playing (games, activities) on his/her own or is interested in learning new things (such as the alphabet or a new sport). The CMS is available in the original publication65. It is scored by deriving a total score of the 16 items which may range from 0 to 64, where higher scores represent greater motivation and lower scores indicate poor motivation. Normative values have been reported as mean of 50, standard deviation of 10, with clinical values indicative of poor motivation on a US inpatient psychiatric unit and outpatient affective disorder clinic as mean of 31, standard deviation of 1065. This measure was forward and back translated and administered to participants in their home language by trained research staff.
Clinical measures
Treatment status of children was documented as either on ART or ART-naïve as per the parent study17,66. Current CD4 + cell count and HIV viral load data were collected from results of the most recent blood tests taken at outpatient clinics. Encephalopathy was assessed based on a comprehensive neuromedical assessment by a clinician specialised in paediatric neurodevelopment67.
Neuropsychological assessment
A neuropsychological test battery was administered to all children to assess global cognitive function and frontostriatal performance, as well as specific cognitive domains, of which attention, working memory, processing speed and executive function were examined in detail in this nested study. These domains have been specifically linked to apathy in adults and are sensitive to fronto-subcortical deficits associated with HIV. The test battery included the Weschler Intelligence Scale for Children (WISC-IV)68 Colour Trails 169, Test of Everyday Attention for Children WISC Digit Span Backwards68, NEPSY-II Inhibition, Switching and Naming subtests70, Category and Phonetic fluency, Colour Trails 269, and the Wechsler Abbreviated Scale of Intelligence Matrix Reasoning and Similarities subtests68. These are standardised neuropsychological assessments that are routinely used in paediatric clinical and research settings in South Africa and globally17. Test content and instructions were forward and back translated into the local language, isiXhosa, to ensure the original and translated versions matched each other, and were culturally appropriate17. All tests were administered to participants in their home language by trained research staff.
Diffusion tensor imaging
Image acquisition
Diffusion Tensor Imaging (DTI) was performed at the Cape Universities Brain Imaging Centre (CUBIC), Tygerberg Hospital using a 3 T Siemens Allegra MRI scanner. Images were captured with a single-channel transmit-receive head coil in axial orientation with diffusion weighted parameters: TE = 88 ms, TR = 8800 ms, FOV = 22 cm, 65 slices, 1.8 × 1.8 × 2.0 mm3 spatial resolution, 0% distance factor and two-fold GRAPPA acceleration. Gradients were applied in 30 directions with b = 1000 mm/s2 and 3 directions with b = 0 mm/s2. The 5-min sequence was repeated 3 times per child, and acquisitions with poor image quality were excluded. All scans were clinically reported and children were referred on to the appropriate services if indicated.
Image processing
FSL (FMRIB Software Library) 4.8 toolbox was used to correct for eddy current and motion distortions71. Further preprocessing was then carried out in MATLAB (Mathworks, Natick, MA) R2012b using a series of in-house scripts. Images were affine registered to the first acquisition’s b = 0 mm/s2 image and outlier data points were excluded. Each child’s corrected acquisitions were then averaged and imported into FSL 4.8 for further processing. Fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AD) image maps were generated using a linear fit of the tensor model to the diffusion-weighted data. Pre-processed data were visually checked to ensure that images presented with no significant distortions.
Following brain extraction with FSL BET71, with the fractional intensity threshold specified at 0.2 to exclude non-brain voxels, the tract-based spatial statistics process (TBSS) for whole-brain and region of interest (ROI) was used to analyse FA images72. As the adult template included with TBSS is not suitable for paediatric images, a single subject’s FA image was selected to be the study-specific target for registration. The target was identified by first registering every subject’s FA image to each other, and then choosing the image with the minimum mean displacement to be representative of the group.
All FA images were then aligned to the target image space and upsampled to MNI space, allowing for the previous estimated registration limits. A mean FA skeleton was then generated from the averaged thinned FA image. This skeleton corresponds to the centre of white matter tracts shared by the cohort and was thresholded at 0.2. All pre-aligned FA, MD, AD and RD data were projected onto the mean FA skeleton image, and a distance map created of each subject image from the skeleton. ROI masks were created to delineate white matter regions using the JHU-81 white matter atlas included with FSL73. Specific frontostriatal regions were selected a priori for inclusion based on literature assessing pathways for motivation as well as neuroimaging studies of HIV: corpus callosum genu, fornix, anterior limb of internal capsule, anterior and superior corona radiata, cingulum, and the superior longitudinal fasciculus. FA, MD, AD and RD values were extracted for these regions for analysis.
Statistical analyses
Demographic and clinical variables, and motivation levels within the cohort were described. Data were assessed for normality and parametric or non-parametric tests were conducted accordingly. Independent t-tests, Chi-squared tests and ANOVAs were used to examine grouped data comparing sociodemographic variables between ART-naïve slow progressors and children on ART.
The primary outcome was child motivation as measured by the CMS. This was analysed as a continuous scale in order to maintain statistical power, however, different cut-offs were explored relating to previously published normative values65. Mean and standard deviation scores were calculated and compared with that of a normative population (mean 50, SD 10) and previously published values for a clinically apathetic population (mean of 31, SD 10).
CMS scores were compared between children who were treated with ART and ART-naïve slow progressors using unpaired t-tests. Correlation analyses were then conducted between CMS scores and the following variables: (i) child age and education; (ii) disease markers including current CD4 + cell count and viral load; and (iii) cognitive domain scores (derived by calculating an average of the included tests). Pearson’s or Spearman’s coefficients were used as appropriate based on data distribution.
Finally, we examined associations between white matter microstructure and motivation. Pearson’s correlations were performed between CMS score and FA, MD, RD and AD values in ROIs selected a priori. Any relationships that were significant at the bivariate level were further explored using multiple linear regression models including child age, sex and ART use as covariates.
All tests were 2-tailed with a significance level of p < 0.05. Analyses were completed using Stata version 14.2.
Ethics
The Human Research Ethics Committee of the University of Cape Town’s Faculty of Health Sciences granted ethical approval for the larger research programme within which this one was nested. Written informed consent was obtained from parents/legal guardians for the child to participate in the study, and the child provided assent. The study was conducted in accordance with ethical standards and relevant institutional guidance.
Results
Demographic and clinical characteristics
A total of 76 CLWH who had a completed Children’s Motivation Scale (CMS) were included in this study. Demographic and clinical characteristics of all 76 eligible children are shown in Table 1. The median age was 9.9 years, ranging from 6 to 17 years, and 46% were female. A total of 59% children had repeated at least one grade at school and the median highest grade passed was 3, a reflection of years of completed schooling. The median family resources scale total was 71.5 out of a total 150 indicating a high perceived resource and support inadequacy. All children were perinatally infected with HIV. The median CD4 + cell count was 805 (standard deviation (SD) 713), 11% having a CD4 + cell count < 500, while 72.6% had undetectable viral loads. Half had a history of HIV-related illness including bronchitis, pneumonia, TB; no children reported current HIV-related illnesses.
Of the included children, 13 (17%) children were ART-naïve while 63 (83%) were on ART. All children on ART had been on treatment for a minimum of 6 months; of those with regimen information available, 33/43 (76.7%) were still on triple first line ART, while 9 (20.9%) were on second line and 1 (2.3%) child was on third line. There were no significant between-group differences in demographic variables between ART-naïve (n = 13) and treated patients (n = 63) (Table 1). However, ART-treated patients had higher CD4 + cell counts (median 901 versus 558, p = 0.004), and lower log viral loads (median 1.30 versus 3.57, p = 0.002).
Children’s motivation scale scores
CMS scores for the whole cohort were on a scale of 0 to 64 with lower scores reflecting more severe lack of motivation. The overall mean score on the CMS was 35.70 (SD 5.87) with a range from 22 to 52. The mean score was significantly lower than that of the normative population (mean of 50, SD 10) p < 0.0001. Further exploring the association between HIV and lack of motivation using the 25th percentile of the CMS (score of 32; equivalent to mean plus 2 SD below the CMS mean of averaged previously reported paediatric normative samples65) as a threshold indicated 28% of children in this group had substantial lack of motivation.
There were no significant correlations between motivation and age (rho = 0.03, p = 0.82) or education level (rho = 0.001, p = 0.99) (Supplementary Table S1), and no difference in CMS score by child sex (t-test = − 0.22, p = 0.83).
Motivation and markers for disease progression
CMS scores were not correlated with either absolute CD4 + cell count (rho) = − 0.16, p = 0.19) or HIV viral load (rho = 0.06, p = 0.63) (Supplementary Table S1). Similarly, there were no differences comparing categorical CD4 + cell count < 500 or > 500 (p = 0.61), detectable versus undetectable viral load (p = 0.35), or children with and without a history of HIV-related illness (p = 0.87).
A comparison of the scores of children based on ART showed the mean CMS score for ART-naïve slow-progressor children was 39.15 (6.12) versus ART-treated 34.98 (5.60), and the ART-treated children demonstrated significantly lower CMS scores (t: 2.40, p = 0.02) (Fig. 1). Given children on ART had lower scores, we went on to examine whether there was any effect of prior encephalopathy. 18 children had been given a diagnosis of HIV encephalopathy prior to entering the study and all were established on ART. A sub analysis of those children on ART with (n = 18) and without encephalopathy (n = 45) showed they did not significantly differ in CMS score (mean 34.56 (6.35) versus 35.16 (5.35), t = 0.38, p = 0.70).
Motivation and cognition
Overall, all cognitive domain z-score means were below 0, indicating children scored below the equivalent average standard from HIV-negative data with z-scores ranging from − 0.16 to − 0.56. There were no significant correlations (p < 0.05) found between cognitive domain scores, global, or frontostriatal composite scores and the CMS (Table 2).
Motivation and Neuroimaging
Of the 66 children with DTI, 61 neuroimaging sequences were included in the final neuroimaging analysis and 5 children were excluded due to motion artefacts. There were no significant differences in underlying demographic and clinical variables (age, sex, race, education, CD4 + cell count, viral load, ART) between the 61 children included, and the 15 children without scan data (Supplementary Table S2). Mean FA values for regions of interest by ART group are included in Supplementary Table S3.
Bivariate analyses of CMS score and DTI metrics were undertaken within a priori regions. Statistically significant correlations between CMS and FA, MD and RD are shown in Table 3 and Fig. 2a (there were no significant correlations in AD). Negative correlations were observed between CMS and FA in the anterior limb of the internal capsule bilaterally and the superior corona radiata (right), and positive correlations with MD in the cingulum (right), and RD in the cingulum (bilaterally).
For ROIs which showed significant bivariate correlations, multiple regression analyses were performed with CMS score as the dependent variable, DTI values as predictors, and age, sex and ART use as covariates. FA values in the right and left anterior limb of the internal capsule remained significant predictors of CMS score (beta = − 0.32, p = 0.02, and beta = − 0.29, p = 0.04 respectively) (Table 3, Fig. 2b; Supplementary Table S4). ART use also accounted for some of the CMS score in these regions (beta = − 0.32, p = 0.01, and beta = − 0.28, p = 0.03).
Discussion
This study investigated motivation levels, clinical and cognitive correlates, and white matter microstructure in CLWH. We found that: (1) CLWH scored low on the CMS indicating poor motivation levels; (2) CLWH treated with ART had significantly lower motivation levels compared to ART-naïve slow progressors; (3) there were no correlations between motivation levels and cognitive function or current markers of HIV disease; however, (4) there were significant associations between motivation levels and white matter microstructure in specific frontostriatal regions, particularly the anterior limb of the internal capsule.
Apathy has been well-described in the adult HIV literature and this study demonstrates that problems with motivation may also affect children. This may have key implications given ongoing problems described in school performance in CLWH74. Our results are consistent with the one previously published study examining motivation in CLWH, suggesting lack of motivation may be an important symptom in CLWH20. Developmental psychology describes how infants are born with an intrinsic motivation75, however, in our study most CLWH fell below the normal motivation range previously reported65,76,77, and over a quarter present with substantial lack of motivation. This prevalence is similar to estimations of clinically significant apathy (26%) in adults living with HIV26.
Lower motivation levels were found in the ART-treated group compared to ART-naïve slow progressor children. CLWH on ART are more likely to have had a faster disease progression leading to ART initiation given prior HIV guidelines where ART initiation was based on disease severity, compared to ART-naïve slow progressor children who have not had an AIDS-defining illness and are able to maintain virological suppression without treatment18. Thus, it may be inferred that although lack of motivation can occur prior to significant immune suppression, it has been shown here to occur more frequently in those treated with ART potentially related to more extensive HIV CNS invasion. This is particularly concerning as CLWH are often on complicated ART regimens with multiple side effects and need to be motivated to maintain optimum medication adherence40,41, and adult studies indicate an association between apathy and poorer medication adherence36,78,79.
Motivation levels did not correlate with age, education, or laboratory markers of HIV disease (current CD4 + cell count, viral load). These results are consistent with adult literature suggesting apathy may present without major immune compromise26, and may not show a relationship with current CD49,24,34. The general level of neurocognitive function was low, similar to prior reports showing cognitive impairments in CLWH compared to controls52. However, there was no evidence of an association between motivation levels and cognitive scores in the executive function, attention, processing speed and working memory domains. This finding is similar to that of other research in adults using varying measures of apathy25,30, although the literature from adults is inconsistent as some studies show an association between apathy and cognition9,59,80. Previous studies have indicated that the relationship between cognition and apathy is mainly seen in adults with HIV who had greater cognitive impairment24, and it is possible the children in this study did not have the same degree of impairment to show an association. In addition, motivation and cognitive processes are in different circuits in the brain which may require substantial damage before both are affected59.
Using DTI, we identified a relationship between motivation score and white matter microstructure, similar to adult studies of apathy and HIV33,60. In particular, DTI metrics in the anterior limb of the internal capsule, superior corona radiata, and the cingulum were correlated with CMS score suggesting white matter integrity in these regions is associated with motivation. The anterior limb of the internal capsule is a white matter subcortical structure situated between the caudate nucleus (medially) and the lentiform nucleus (laterally). It predominantly contains thalamic and brainstem fibres connecting the thalamus with the prefrontal cortex (thalamocortical and corticothalamic) and the frontal lobe with the pontine nuclei (frontopontine), as well as transverse fibres connecting the caudate and putamen81,82. The anterior limb of the internal capsule is known to be important in frontostriatal pathways that are often affected by HIV56,57,83. Frontostriatal circuits connecting the frontal cortex and basal ganglia are known to be involved in motivation53, and damage to this area has been suggested as the common mechanism leading to apathy in HIV in adults9,59. Microstructural differences between CLWH and controls have been described irrespective of ART status in these regions52,61. Suggested mechanisms include dopamine deficits84, and direct effects of HIV-1 proteins leading to synaptic dysfunction and dysregulation of motivational processes85,86.
Higher motivation was associated with lower FA, a measure of white matter integrity, whilst lower motivation was associated with higher MD and RD17,87,88 in the specific frontostriatal regions. The direction of effect is similar to correlations between DTI metrics and motivation that have been previously reported in adolescents89, however, it differs to some previous research in adults living with HIV33. In this case, findings in children may be separate to adults, and we hypothesise that decreased FA may represent more axons with increased numbers of crossing fibres in the white matter matrix causing a paradoxical decrease in FA46. This fits with results from other HIV studies66,90, particularly those examining the internal capsule91.
Strengths of this study lie in a well-characterised sample of children, with validated neurocognitive tests, and unique neuroimaging data from South Africa, which has the highest number of CLWH worldwide. However, several limitations are to be noted, firstly the cross-sectional design of this study means it is not possible to infer causality. Longitudinal studies are needed to understand the trajectory of motivation in comparison to controls over time. Secondly, there was heterogeneity in the sample and current CD4 + cell count and viral load are time-dependent variables which may not be optimum markers of disease activity; CD4 nadir data were not available but this would be useful to examine in future studies, along with investigating the effects of specific antiretroviral drugs and greater child numbers to allow more detailed characterization. However, this is considered a large sample size in the child HIV neuroimaging literature. Third, there are no validated clinical cut-off values for apathy, and in the absence of normative data for South African paediatric populations the only comparison we can make is with the original population published in the literature; further validation in low and middle-income countries is needed, along with research into whether parents’ perception of child motivation may be biased by illness, and development of appropriate child-completed measures of motivation. Fourth, while diverse regions have been described to be affected by HIV across cross-sectional DTI studies at different ages, in this study we focused on frontostriatal regions for their association with motivation. Given the potential for a diffuse effect of HIV, future studies should aim to explore the involvement of other brain regions with large enough populations to withstand multiple comparisons. Lastly, we do not have an HIV negative control group. Motivation in children is complex and it may not be possible to isolate from other external and internal factors including the environment, parenting behaviour, or exposure to trauma, which play a key role in motivation levels in children92. Further research studies are warranted that compare children living with and without HIV to understand this construct further.
Conclusions
In conclusion, the results suggest that lack of motivation may be an important neurobehavioural symptom in CLWH, reflecting changes in white matter microstructure in frontostriatal regions, and which has implications for clinical care. As ART usage continues to increase, the population of CLWH progressing into adolescence is growing and long-term neuropsychological sequelae are becoming increasingly important to understand. This study demonstrates the value of assessing motivation in CLWH, and further work is needed to assess the possible value of motivation as a treatment target.
Data availability
The data presented in this study are available upon reasonable request from the corresponding author.
References
UNAIDS. AIDSinfo. http://aidsinfo.unaids.org. Accessed 6th October, 2023.
Newell, M. L. et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. Lancet 364, 1236–1243 (2004).
Govender, R., Eley, B., Walker, K., Petersen, R. & Wilmshurst, J. M. Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J. Child Neurol. 26, 1355–1364 (2011).
McHenry, M.S., et al. Neurodevelopment in Young Children Born to HIV-Infected Mothers: A Meta-analysis. Pediatrics 141 (2018).
Valcour, V., Sithinamsuwan, P., Letendre, S. & Ances, B. Pathogenesis of HIV in the central nervous system. Curr. HIV/AIDS Rep. 8, 54–61 (2011).
Wachsler-Felder, J. L. & Golden, C. J. Neuropsychological consequences of HIV in children: A review of current literature. Clin. Psychol. Rev. 22, 443–464 (2002).
Chase, C., et al. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics 106, E25 (2000).
Foster, C. J. et al. Neurodevelopmental outcomes in children with HIV infection under 3 years of age. Dev. Med. Child Neurol. 48, 677–682 (2006).
Castellon, S. A., Hinkin, C. H., Wood, S. & Yarema, K. T. Apathy, depression, and cognitive performance in HIV-1 infection. J. Neuropsychiatry Clin. Neurosci. 10, 320–329 (1998).
Gray, F. et al. Neuropathology of early HIV-1 infection. Brain Pathol. 6, 1–15 (1996).
Van Rie, A., Harrington, P. R., Dow, A. & Robertson, K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. Eur. J. Paediatr. Neurol. 11, 1–9 (2007).
Laughton, B., Cornell, M., Boivin, M. & Van Rie, A. Neurodevelopment in perinatally HIV-infected children: A concern for adolescence. J. Int. AIDS Soc. 16, 18603 (2013).
De Baets, A. J., Bulterys, M., Abrams, E. J., Kankassa, C. & Pazvakavambwa, I. E. Care and treatment of HIV-infected children in Africa: Issues and challenges at the district hospital level. Pediatr. Infect. Dis. J. 26, 163–173 (2007).
UNICEF. Paediatric care and treatment. (2021) https://data.unicef.org/topic/hivaids/paediatric-treatment-and-care. Accessed 5th January, 2022.
Nozyce, M. L. et al. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 117, 763–770 (2006).
Boivin, M. J. et al. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol. 14, 13–21 (1995).
Hoare, J. et al. A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naive “slow progressors”. J. Neurovirol. 18, 205–212 (2012).
Bagenda, D. et al. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics 117, 729–740 (2006).
van Wyhe, K. S. et al. Cognitive outcomes at ages seven and nine years in South African children from the children with HIV early antiretroviral (CHER) trial: A longitudinal investigation. J. Int. AIDS Soc. 24, e25734 (2021).
Hoare, J. et al. Mental health and functional competence in the cape town adolescent antiretroviral cohort. J. Acquired Immune Def. Syndromes 81, E109–E116 (2019).
APA Dictionary of Psychology. American Psychological Association. https://dictionary.apa.org/motivation. Accessed 4 October, 2023.
Rosenbrock, H., Desch, M. & Wunderlich, G. Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 273, 1557–1566 (2023).
Williams, C., Wood, R. L., Alderman, N. & Worthington, A. The psychosocial impact of neurobehavioral disability. Front. Neurol. 11 (2020).
Paul, R. et al. Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J. Neuropsychiatry Clin. Neurosci. 17, 114–118 (2005).
Rabkin, J. G. et al. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J. Neuropsychiatr. Clin. Neurosci. 12, 451–457 (2000).
Tate, D. et al. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDs 17, 115–120 (2003).
Diederich, N., et al. Early involvement of the nervous system by human immune deficiency virus (HIV). A study of 79 patients. Eur. Neurol. 28, 93–103 (1988).
Marin, R. S. Differential diagnosis and classification of apathy. Am. J. Psychiatry 147, 22–30 (1990).
Marin, R. S., Biedrzycki, R. C. & Firinciogullari, S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 38, 143–162 (1991).
Bryant, V. E. et al. Depression and apathy among people living with HIV: Implications for treatment of HIV associated neurocognitive disorders. Aids Behav. 19, 1430–1437 (2015).
Kamat, R. et al. Incident major depressive episodes increase the severity and risk of apathy in HIV infection. J. Affect Disord. 175, 475–480 (2015).
Kamat, R., Woods, S. P., Cameron, M. V. & Iudicello, J. E. Apathy is associated with lower mental and physical quality of life in persons infected with HIV. Psychol. Health Med. 21, 890–901 (2016).
Hoare, J. et al. White matter correlates of apathy in HIV-positive subjects: A diffusion tensor imaging study. J. Neuropsychiatry Clin. Neurosci. 22, 313–320 (2010).
Shapiro, M. E., Mahoney, J. R., Zingman, B. S., Pogge, D. L. & Verghese, J. Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals. J. Clin. Exp. Neuropsychol. 35, 934–945 (2013).
Kamat, R., Woods, S. P., Marcotte, T. D., Ellis, R. J. & Grant, I. Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Arch. Clin. Neuropsychol. 27, 520–531 (2012).
Barclay, T. R. et al. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 26, 40–49 (2007).
van Reekum, R., Stuss, D. T. & Ostrander, L. Apathy: Why care?. J. Neuropsychiatr. Clin. Neurosci. 17, 7–19 (2005).
Brook, M. G. et al. Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units. AIDS Patient Care STDS 15, 491–494 (2001).
Ngarina, M., Popenoe, R., Kilewo, C., Biberfeld, G. & Ekstrom, A. M. Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: Experiences from the Mitra Plus study in Tanzania. BMC Public Health 13, 450 (2013).
Nachega, J. B. et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in Southern Africa. JAIDS J. Acquired Immune Def. Syndr. 51, 65–71 (2009).
Haberer, J. & Mellins, C. Pediatric adherence to HIV antiretroviral therapy. Curr. HIV/AIDS Rep. 6, 194–200 (2009).
Van den Hof, M., et al. Brain structure of perinatally HIV-infected patients on long-term treatment. Neurol. Clin. Pract. 9, 433 (2019).
Musielak, K. A. & Fine, J. G. An updated systematic review of neuroimaging studies of children and adolescents with perinatally acquired HIV. J. Pediatr. Neuropsychol. 2, 34–49 (2015).
Hoare, J. et al. Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents. Metab. Brain Dis. 29, 221–229 (2014).
Filippi, C. G., Ulug, A. M., Ryan, E., Ferrando, S. J. & van Gorp, W. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR. Am. J. Neuroradiol. 22, 277–283 (2001).
Jones, D. K., Knosche, T. R. & Turner, R. White matter integrity, fiber count, and other fallacies: The do’s and don’ts of diffusion MRI. Neuroimage 73, 239–254 (2013).
Li, J. et al. White matter development is potentially influenced in adolescents with vertically transmitted HIV infections: a tract-based spatial statistics study. AJNR. Am. J. Neuroradiol. 36, 2163–2169 (2015).
Ackermann, C. et al. Early antiretroviral therapy in HIV-infected children is associated with diffuse white matter structural abnormality and corpus callosum sparing. AJNR. Am. J. Neuroradiol. 37, 2363–2369 (2016).
Jankiewicz, M. et al. White matter abnormalities in children with HIV infection and exposure. Front. Neuroanat. 11, 88 (2017).
Uban, K. A. et al. White matter microstructure among youth with perinatally acquired HIV is associated with disease severity. Aids 29, 1035–1044 (2015).
Cohen, S. et al. Cerebral injury in perinatally HIV-infected children compared to matched healthy controls. Neurology 86, 19–27 (2016).
Hoare, J., et al. White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa. Aids 29 (2015).
Bonelli, R. M. & Cummings, J. L. Frontal-subcortical dementias. Neurology 14, 100–107 (2008).
Andersson, S. & Bergedalen, A. M. Cognitive correlates of apathy in traumatic brain injury. Neuropsychiatry Neuropsychol. Behav. Neurol. 15, 184–191 (2002).
Bhatia, K. P. & Marsden, C. D. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain J. Neurol. 117(Pt 4), 859–876 (1994).
Gongvatana, A. et al. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J. Neurovirol. 15, 187–195 (2009).
Paul, R., Cohen, R., Navia, B. & Tashima, K. Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci. Biobehav. Rev. 26, 353–359 (2002).
McIntosh, R. C., Rosselli, M., Uddin, L. Q. & Antoni, M. Neuropathological sequelae of Human Immunodeficiency Virus and apathy: A review of neuropsychological and neuroimaging studies. Neurosci. Biobehav. Rev. 55, 147–164 (2015).
Paul, R. H. et al. Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J. Neuropsychiatry Clin. Neurosci. 17, 167–171 (2005).
Kamat, R. et al. Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection. J. Clin. Exp. Neuropsychol. 36, 854–866 (2014).
Hoare, J. et al. Structural brain changes in perinatally HIV-infected young adolescents in South Africa. Aids 32, 2707–2718 (2018).
Cole, M. A. et al. Relationship between psychiatric status and frontal-subcortical systems in HIV infected individuals. J. Int. Neuropsychol. Soc. 13, 549–554 (2007).
Hoare, J. et al. Applying the HIV-associated neurocognitive disorder diagnostic criteria to HIV-infected youth. Neurology 87, 86–93 (2016).
Dunst, C.J. & Leet, H.E. Family resource scale (FRS) APA PsycTests (1987).
Gerring, J. P. et al. Psychometric characteristics of the Children’s Motivation Scale. Psychiatry Res. 63, 205–217 (1996).
Hoare, J. et al. White-Matter damage in Clade C HIV-positive subjects: a diffusion tensor imaging study. J. Neuropsychiatry Clin. Neurosci. 23, 308–315 (2011).
Donald, K. A. et al. HIV Encephalopathy: pediatric case series description and insights from the clinic coalface. AIDS Res. Ther. 12, 2 (2015).
Wechsler, D. Wechsler abbreviated scale of intelligence (Psychologial Corporation, 1999).
Williams, J. et al. Children’s color trails. Arch. Clin. Neuropsychol. 10, 211–223 (1995).
Korkman, M., Kirk, U. & Kemp, S. NEPSY-II, (Psychological Coporation, San Antonio, 2007).
Smith, S. M. Fast robust automated brain extraction. Hum. Brain Map. 17, 143–155 (2002).
Smith, S. M. et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31, 1487–1505 (2006).
Mori, S., Wakana, S., Nagae-Poetscher, L. & van Zijl, P. MRI atlas of human white matter, (Elsevier, Amsterdam (The Netherlands), 2005).
van Opstal, S. E. M. et al. School functioning of children with perinatal HIV-infection in high-income countries: A systematic review. PLoS ONE 16, e0252746 (2021).
White, R. W. Motivation reconsidered: The concept of competence. Psychol. Rev. 66, 297–333 (1959).
Bat Or, M. FEATS Problem-Solving Scale in PPAT of children aged 5–6.5 as related to their executive functions and motivation. Arts Psychother. 41, 27–35 (2014).
Max, J. E. et al. Attention deficit hyperactivity disorder and neurocognitive correlates after childhood stroke. J. Int. Neuropsychol. Soc. 9, 815–829 (2003).
Panos, S. E. et al. The impact of neurobehavioral features on medication adherence in HIV: Evidence from longitudinal models. AIDS Care 26, 79–86 (2014).
Babicz, M. A., Woods, S. P., Fazeli, P. & Morgan, E. E. Apathy is associated with critical psychological determinants of medication adherence in HIV disease. J. Clin. Psychol. Med. Settings 28, 301–312 (2021).
Castellon, S. A., Hinkin, C. H. & Myers, H. F. Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. J. Int. Neuropsychol. Soc. 6, 336–347 (2000).
Ziad, S. et al. Functional segmentation of the anterior limb of the internal capsule: Linking white matter abnormalities to specific connections. J. Neurosci. 38, 2106 (2018).
Emos, M. C., Khan Suheb, M. Z. & Agarwal, S. Neuroanatomy, internal capsule. [Updated 2023 Jun 5]. https://www.ncbi.nlm.nih.gov/books/NBK542181/ (StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023 Jan).
Aylward, E. H. et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43, 2099–2104 (1993).
McLaurin, K.A., et al. HIV-Associated apathy/depression and neurocognitive impairments reflect persistent dopamine deficits. Cells 10 (2021).
Bertrand, S. J., Mactutus, C. F., Harrod, S. B., Moran, L. M. & Booze, R. M. HIV-1 proteins dysregulate motivational processes and dopamine circuitry. Sci. Rep. 8 (2018).
McLaurin, K. A. et al. Synaptic connectivity in medium spiny neurons of the nucleus accumbens: A sex-dependent mechanism underlying apathy in the HIV-1 transgenic rat. Front. Behav. Neurosci. 12, 285 (2018).
Chen, Y. et al. White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage 47, 1154–1162 (2009).
Song, S. K. et al. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17, 1429–1436 (2002).
Chung, T., Pajtek, S. & Clark, D. B. White matter integrity as a link in the association between motivation to abstain and treatment outcome in adolescent substance users. Psychol. Addict. Behav. 27, 533–542 (2013).
Stebbins, G. T. et al. HIV-associated alterations in normal-appearing white matter: A voxel-wise diffusion tensor imaging study. J. Acquir. Immune Defic. Syndr. 46, 564–573 (2007).
Pomara, N., Crandall, D. T., Choi, S. J., Johnson, G. & Lim, K. O. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res. 106, 15–24 (2001).
Robichaud, J., Roy, M., Ranger, F. & Mageau, G. The impact of environmental threats on controlling parenting and children’s motivation. J. Family Psychol. 34, 804–813 (2020).
Acknowledgements
We thank the study caregivers and children without whom this research would not have been possible. We thank the dedicated radiographers at the Cape Universities Brain Imaging Centre and Henri Carrara for statistical support.
Funding
This was work was funded by the South African Medical Research Council (MRC) and National Research Foundation of South Africa. CJW was supported by the Wellcome Trust [203525/Z/16/Z].
Author information
Authors and Affiliations
Contributions
Conceptualization: J.H. (principal investigator of the project), D.J.S.; investigation: N.J.P., J.P.F., J.H.; methodology: C.J.W., N.J.P., J.P.F., J.H., D.J.S., S.D.L.; formal analysis: C.J.W.; writing—original draft preparation: C.J.W.; writing—review and editing: C.J.W., T.S., J.P.F., N.J.P., S.D.L., D.J.S., J.H.; resources: T.S., D.J.S., J.H.; supervision: S.D.L., D.J.S., J.H.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wedderburn, C.J., Sevenoaks, T., Fouche, JP. et al. Motivation levels and white matter microstructure in children living with HIV. Sci Rep 14, 4425 (2024). https://doi.org/10.1038/s41598-024-54411-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-54411-3
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.